S. Aubrey Stoch
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Bone health and treatments, Bone health and osteoporosis research, Pharmacogenetics and Drug Metabolism, Bone Metabolism and Diseases
Most-Cited Works
- → Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists1(2001)186 cited
- → Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide1Bclinical probe than rosuvastatin(2014)163 cited
- → Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies(2009)156 cited
- → Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women(2005)136 cited
- → Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor(2023)124 cited
- → Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial(2009)98 cited